Lab Reagents
Human IgG antibody Laboratories manufactures the covidtest jena bioscience apo reagents distributed by Genprice. The Covidtest Jena Bioscience Apo reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Jena Bioscience GmbH. Other Covidtest products are available in stock. Specificity: Covidtest Category: Jena Group: Bioscience Apo
Bioscience Apo information
Apo AII Protein |
abx069752-05mg |
Abbexa |
0.5 mg |
EUR 460.8 |
|
Apo E Protein |
abx069753-005mg |
Abbexa |
0.05 mg |
EUR 560.4 |
|
Apo H Protein |
abx069757-1mg |
Abbexa |
1 mg |
EUR 1554 |
|
APO-D Protein |
20-abx263521 |
Abbexa |
-
EUR 994.80
-
EUR 493.20
-
EUR 644.40
|
|
|
Apo Transferrin Peptide |
abx260006-1gr |
Abbexa |
1 gr |
EUR 777.6 |
|
Apo Transferrin Peptide |
abx260006-500mg |
Abbexa |
500 mg |
EUR 560.4 |
|
Apo Transferrin Peptide |
abx260006-5grs |
Abbexa |
5 grs |
EUR 2498.4 |
|
APO-E Antibody |
7333-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: APO-E Antibody: Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E (APO-E), a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. Defects in APO-E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. |
APO-E Antibody |
7333-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: APO-E Antibody: Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E (APO-E), a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. Defects in APO-E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. |
APO-E Peptide |
7333P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) APO-E Peptide |
Clusterin/Apo J |
GT15117 |
Neuromics |
100 ug |
EUR 631.2 |
Apo Transferrin (ATF) |
PR27104 |
Neuromics |
500 mg |
EUR 522 |
Clusterin/APO-J |
PR27111 |
Neuromics |
2 ug |
EUR 229.2 |
Apo-12'-lycopenal |
TBW00395 |
ChemNorm |
5mg |
EUR 580.8 |
Apo-SAA, human recombinant |
4324-10 |
Biovision |
|
EUR 164.4 |
Apo-SAA, human recombinant |
4324-1000 |
Biovision |
|
EUR 1104 |
Apo-SAA, human recombinant |
4324-50 |
Biovision |
|
EUR 307.2 |